Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongming Qu

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Pharmaceutical Statistics|July 16, 2021
A unified approach for evaluating the prediction of treatment effect across different types of endpointsYongming Qu, So Young Park, Qiwei Wu, et al.
Current Medical Research and Opinion|December 22, 2005
The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trialYongming Qu, Mayme Wong, Daniel Thiebaud, et al.
Therapeutic Innovation & Regulatory Science|July 17, 2025
Estimand Endpoints for Longitudinal Measures of Continuous Disease Progression with an Alzheimer's Disease ExampleHaoyan Hu, Miroslaw Brys, Stephen J Ruberg, et al.
Statistics in Medicine|February 24, 2011
Covariate-adjusted non-parametric survival curve estimationHonghua Jiang, James Symanowski, Yongming Qu, et al.
Journal of Biopharmaceutical Statistics|October 26, 2018
Modeling the impact of preplanned dose titration on delayed responseYongming Qu, Zhuqing Liu, Haoda Fu, et al.
Therapeutic Innovation & Regulatory Science|September 26, 2023
Non-monotone Exponential Time (NEXT) Model for the Longitudinal Trend of a Continuous Outcome in Clinical TrialsRan Duan, Kaiyi Chen, Yu Du, et al.
Current Medical Research and Opinion|April 9, 2008
Quantifying the effect of exenatide and insulin glargine on postprandial glucose excursions in patients with type 2 diabetesRobert G Brodows, Yongming Qu, Don Johns, et al.
Statistics in Medicine|July 19, 2022
Using principal stratification in analysis of clinical trialsIlya Lipkovich, Bohdana Ratitch, Yongming Qu, et al.
Cardiovascular Diabetology|May 19, 2016
Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysisByron J Hoogwerf, A Michael Lincoff, Angel Rodriguez, et al.
Statistics in Medicine|December 3, 2025
Bayesian Integrated Learning of Longitudinal Dose-Response Relationships via Decentralized Clinical TrialsJingyi Zhang, Tuo Wang, Yongming Qu, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Pharmaceutical Statistics|July 16, 2021
A unified approach for evaluating the prediction of treatment effect across different types of endpointsYongming Qu, So Young Park, Qiwei Wu, et al.
Current Medical Research and Opinion|December 22, 2005
The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trialYongming Qu, Mayme Wong, Daniel Thiebaud, et al.
Therapeutic Innovation & Regulatory Science|July 17, 2025
Estimand Endpoints for Longitudinal Measures of Continuous Disease Progression with an Alzheimer's Disease ExampleHaoyan Hu, Miroslaw Brys, Stephen J Ruberg, et al.
Statistics in Medicine|February 24, 2011
Covariate-adjusted non-parametric survival curve estimationHonghua Jiang, James Symanowski, Yongming Qu, et al.
Journal of Biopharmaceutical Statistics|October 26, 2018
Modeling the impact of preplanned dose titration on delayed responseYongming Qu, Zhuqing Liu, Haoda Fu, et al.
Therapeutic Innovation & Regulatory Science|September 26, 2023
Non-monotone Exponential Time (NEXT) Model for the Longitudinal Trend of a Continuous Outcome in Clinical TrialsRan Duan, Kaiyi Chen, Yu Du, et al.
Current Medical Research and Opinion|April 9, 2008
Quantifying the effect of exenatide and insulin glargine on postprandial glucose excursions in patients with type 2 diabetesRobert G Brodows, Yongming Qu, Don Johns, et al.
Statistics in Medicine|July 19, 2022
Using principal stratification in analysis of clinical trialsIlya Lipkovich, Bohdana Ratitch, Yongming Qu, et al.
Cardiovascular Diabetology|May 19, 2016
Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysisByron J Hoogwerf, A Michael Lincoff, Angel Rodriguez, et al.
Statistics in Medicine|December 3, 2025
Bayesian Integrated Learning of Longitudinal Dose-Response Relationships via Decentralized Clinical TrialsJingyi Zhang, Tuo Wang, Yongming Qu, et al.
Pageof 8